Many new cancer drugs show 'no clear benefit', argues review

Ciaran Arthurs's picture
"Over half of new cancer drugs 'show no benefits' for survival or wellbeing," The Guardian reports. That was the finding of a study looking at the evidence supporting new cancer drugs approved between 2009 and 2013 by the European Medicines Agency (EMA). The study found only half of drug...
Last modified: 
Monday, 9 October, 2017 - 13:35